224 related articles for article (PubMed ID: 32366855)
21. Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle.
Gameiro PA; Laviolette LA; Kelleher JK; Iliopoulos O; Stephanopoulos G
J Biol Chem; 2013 May; 288(18):12967-77. PubMed ID: 23504317
[TBL] [Abstract][Full Text] [Related]
22. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
23. Availability of the key metabolic substrates dictates the respiratory response of cancer cells to the mitochondrial uncoupling.
Zhdanov AV; Waters AH; Golubeva AV; Dmitriev RI; Papkovsky DB
Biochim Biophys Acta; 2014 Jan; 1837(1):51-62. PubMed ID: 23891695
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy.
Li D; Fu Z; Chen R; Zhao X; Zhou Y; Zeng B; Yu M; Zhou Q; Lin Q; Gao W; Ye H; Zhou J; Li Z; Liu Y; Chen R
Oncotarget; 2015 Oct; 6(31):31151-63. PubMed ID: 26439804
[TBL] [Abstract][Full Text] [Related]
25. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport.
Yang C; Ko B; Hensley CT; Jiang L; Wasti AT; Kim J; Sudderth J; Calvaruso MA; Lumata L; Mitsche M; Rutter J; Merritt ME; DeBerardinis RJ
Mol Cell; 2014 Nov; 56(3):414-424. PubMed ID: 25458842
[TBL] [Abstract][Full Text] [Related]
26. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
[TBL] [Abstract][Full Text] [Related]
27. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.
Mullen AR; Hu Z; Shi X; Jiang L; Boroughs LK; Kovacs Z; Boriack R; Rakheja D; Sullivan LB; Linehan WM; Chandel NS; DeBerardinis RJ
Cell Rep; 2014 Jun; 7(5):1679-1690. PubMed ID: 24857658
[TBL] [Abstract][Full Text] [Related]
28. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
Tanaka K; Sasayama T; Irino Y; Takata K; Nagashima H; Satoh N; Kyotani K; Mizowaki T; Imahori T; Ejima Y; Masui K; Gini B; Yang H; Hosoda K; Sasaki R; Mischel PS; Kohmura E
J Clin Invest; 2015 Apr; 125(4):1591-602. PubMed ID: 25798620
[TBL] [Abstract][Full Text] [Related]
29. Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone.
Ge C; Wang Y; Feng Y; Wang S; Zhang K; Xu X; Zhang Z; Zhao Y; Wang Y; Gao L; Dai F; Xie S; Wang C
Cancer Lett; 2021 Oct; 519():30-45. PubMed ID: 34166768
[TBL] [Abstract][Full Text] [Related]
30. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
Cells; 2019 May; 8(5):. PubMed ID: 31109089
[TBL] [Abstract][Full Text] [Related]
31. Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation.
Corbet C; Pinto A; Martherus R; Santiago de Jesus JP; Polet F; Feron O
Cell Metab; 2016 Aug; 24(2):311-23. PubMed ID: 27508876
[TBL] [Abstract][Full Text] [Related]
32. Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells.
Fendt SM; Bell EL; Keibler MA; Olenchock BA; Mayers JR; Wasylenko TM; Vokes NI; Guarente L; Vander Heiden MG; Stephanopoulos G
Nat Commun; 2013; 4():2236. PubMed ID: 23900562
[TBL] [Abstract][Full Text] [Related]
33. Fatty acid labeling from glutamine in hypoxia can be explained by isotope exchange without net reductive isocitrate dehydrogenase (IDH) flux.
Fan J; Kamphorst JJ; Rabinowitz JD; Shlomi T
J Biol Chem; 2013 Oct; 288(43):31363-9. PubMed ID: 24030823
[TBL] [Abstract][Full Text] [Related]
34. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
[TBL] [Abstract][Full Text] [Related]
35. Reversal of postischemic hypoperfusion by tempol: endothelial signal transduction mechanism.
Okada T; Teranishi K; Chen Y; Tomori T; Strasser A; Lenz FA; McCarron RM; Spatz M
Neurochem Res; 2012 Apr; 37(4):680-8. PubMed ID: 22139482
[TBL] [Abstract][Full Text] [Related]
36. 4-Hydroxy tempol-induced impairment of mitochondrial function and augmentation of glucose transport in vascular endothelial and smooth muscle cells.
Alpert E; Altman H; Totary H; Gruzman A; Barnea D; Barash V; Sasson S
Biochem Pharmacol; 2004 May; 67(10):1985-95. PubMed ID: 15130774
[TBL] [Abstract][Full Text] [Related]
37. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
[TBL] [Abstract][Full Text] [Related]
38. Photorespiration-dependent increases in phospho enolpyruvate carboxylase, isocitrate dehydrogenase and glutamate dehydrogenase in transformed tobacco plants deficient in ferredoxin-dependent glutamine-alpha-ketoglutarate aminotransferase.
Ferrario-Mery S; Hodges M; Hirel B; Foyer CH
Planta; 2002 Apr; 214(6):877-86. PubMed ID: 11941464
[TBL] [Abstract][Full Text] [Related]
39. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
[TBL] [Abstract][Full Text] [Related]
40. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
